BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16897888)

  • 1. [Extracellular matrix proteins and glycoproteins in the cardiovascular system].
    Sasamura H; Saruta T
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():559-64. PubMed ID: 16897888
    [No Abstract]   [Full Text] [Related]  

  • 2. [Regulation of cell proliferation by proteoglycans].
    Yanagishita M
    Tanpakushitsu Kakusan Koso; 1998 Dec; 43(16 Suppl):2589-93. PubMed ID: 9883691
    [No Abstract]   [Full Text] [Related]  

  • 3. Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation.
    Droguett R; Cabello-Verrugio C; Riquelme C; Brandan E
    Matrix Biol; 2006 Aug; 25(6):332-41. PubMed ID: 16766169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proteoglycans].
    Fujisawa R
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():150-4. PubMed ID: 15035115
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adhesive glycoproteins of the extracellular matrix].
    Kwiatkowska D; Kwiatkowska-Korczak J
    Postepy Hig Med Dosw; 1999; 53(1):55-74. PubMed ID: 10352547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteoglycans of the extracellular matrix and growth control.
    Kresse H; Schönherr E
    J Cell Physiol; 2001 Dec; 189(3):266-74. PubMed ID: 11748584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular matrix biology: a new frontier in linking the pathology and therapy of hypertension?
    Tayebjee MH; MacFadyen RJ; Lip GY
    J Hypertens; 2003 Dec; 21(12):2211-8. PubMed ID: 14654734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More evidence on blocking the renin-angiotensin-aldosterone system in cardiovascular disease and the long-term treatment of hypertension: data from recent clinical trials (CHARM, EUROPA, ValHEFT, HOPE-TOO and SYST-EUR2).
    Lip GY; Beevers DG
    J Hum Hypertens; 2003 Nov; 17(11):747-50. PubMed ID: 14578913
    [No Abstract]   [Full Text] [Related]  

  • 9. TGF-beta1 generates a specific multicomponent extracellular matrix in human coronary SMC.
    Schmidt A; Lorkowski S; Seidler D; Breithardt G; Buddecke E
    Eur J Clin Invest; 2006 Jul; 36(7):473-82. PubMed ID: 16796604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of biglycan in the heart.
    Bereczki E; Sántha M
    Connect Tissue Res; 2008; 49(3):129-32. PubMed ID: 18661327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular matrix and cardiovascular diseases.
    Ju H; Dixon IM
    Can J Cardiol; 1996 Dec; 12(12):1259-67. PubMed ID: 8987966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal and stroke protection in hypertensive patients at CV risk.
    Cardiovasc J Afr; 2007; 18(5):337, 340. PubMed ID: 17985036
    [No Abstract]   [Full Text] [Related]  

  • 13. Antihypertensive therapy and de-stiffening of the arteries.
    Safar ME; Jankowski P
    Expert Opin Pharmacother; 2010 Nov; 11(16):2625-34. PubMed ID: 20977399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of proteoglycans in tendinopathy.
    Parkinson J; Samiric T; Ilic MZ; Cook J; Handley CJ
    J Musculoskelet Neuronal Interact; 2011 Jun; 11(2):86-93. PubMed ID: 21625045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive pharmacological agents: beyond their lowering blood pressure effects.
    Miatello RM
    Cell Mol Biol (Noisy-le-grand); 2005 Nov; 51(6):521-3. PubMed ID: 16309575
    [No Abstract]   [Full Text] [Related]  

  • 16. [The future of renin inhibition].
    Uresin AY; Baran E
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extracellular matrix].
    Liu BC; Xu ZL
    Sheng Li Ke Xue Jin Zhan; 1996 Jul; 27(3):221-6. PubMed ID: 9772360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors.
    Heegaard AM; Xie Z; Young MF; Nielsen KL
    J Cell Biochem; 2004 Oct; 93(3):463-75. PubMed ID: 15372625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systolic hypertension as a cardiovascular risk factor.
    McInnes GT
    Blood Press; 2002; 11(3):134-43. PubMed ID: 12126259
    [No Abstract]   [Full Text] [Related]  

  • 20. [Debate concerning the optimal blockage of the renin-angiotensin system].
    Choukroun G
    Nephrol Ther; 2010 Jan; 6 Spec No 1():H1-9. PubMed ID: 20129454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.